Jayne Cottam Acquires 405 Shares of Assura Plc (LON:AGR) Stock

Assura Plc (LON:AGR) insider Jayne Cottam acquired 405 shares of the business’s stock in a transaction dated Wednesday, February 5th. The stock was bought at an average cost of GBX 37 ($0.46) per share, with a total value of £149.85 ($186.36).

Jayne Cottam also recently made the following trade(s):

• On Thursday, December 5th, Jayne Cottam purchased 369 shares of Assura stock. The stock was purchased at an average price of GBX 41 ($0.51) per share, with a total value of £151.29 ($188.15).

Assura Stock Performance

Shares of Assura stock traded down GBX 0.50 ($0.01) during trading on Friday, hitting GBX 37.76 ($0.47). 17,623,359 shares of the stock were exchanged, compared to its average volume of 8,497,083. The company has a current ratio of 0.89, a quick ratio of 2.84 and a debt-to-equity ratio of 85.04. The company has a fifty day moving average price of GBX 37.85 and a 200-day moving average price of GBX 39.85. The stock has a market capitalization of £1.23 billion, a price-to-earnings ratio of -3,776.00, a price-to-earnings-growth ratio of 3.60 and a beta of 0.37. Assura Plc has a 1-year low of GBX 35.24 ($0.44) and a 1-year high of GBX 44.04 ($0.55).

Assura (LON:AGR) last released its quarterly earnings data on Thursday, November 14th. The real estate investment trust reported GBX 1.70 ($0.02) earnings per share (EPS) for the quarter. Assura had a negative return on equity of 1.88% and a negative net margin of 18.25%. As a group, equities analysts predict that Assura Plc will post 3.5830389 EPS for the current fiscal year.

Assura Announces Dividend

The business also recently announced a dividend, which was paid on Wednesday, January 15th. Stockholders of record on Thursday, December 12th were paid a dividend of GBX 0.84 ($0.01) per share. This represents a dividend yield of 2.12%. The ex-dividend date was Thursday, December 12th. Assura’s dividend payout ratio is presently -30,000.00%.

About Assura

Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.

We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).

Assura plc achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.